Ya-Yao HUANG TaiwanCo-Founder and CEOPrimo Biotechnology Co., Ltd.

I have been worked in radiopharmaceutical field for more than 20 years and worked in Taiwan’s top medical center, National Taiwan University Hospital, for 10 years, where was responsible for R&D and GMP-compliant production of PET radiopharmaceuticals for clinical and preclinical use. During 20 years working in academic institutions, I devote to innovative radiopharmaceutical researches for the benefit of all patients, as well as the method development and process improvement of the automated production of radiopharmaceuticals with high quality. In 2021, I founded Primo Biotechnology with my team in order to promote radiopharmaceuticals in Taiwan and Asia in an effective and sustainable way. Moreover, I am delegated as Taiwan ambassador for the non-profit global organization, Oncidium Foundation since 2021 and hope to promote, support and accelerate the development of radiotheranostics for cancer care, worldwide. Now, we are facing similar challenges in precision healthcare even we are in different countries. However, with more and more awareness for radiopharmaceutical effectiveness in clinic, sincerely hope we could have brainstormed to find out the way to tackle these obstacles and let’s work together to achieve a better global healthcare with the advanced and novel radiopharmaceuticals.